Phase II Study of Digitoxin to Treat Cystic Fibrosis
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study will measure the inflammatory effects of digitoxin on IL-8 and neutrophil counts
in induced sputum in stable Cystic Fibrosis (CF) patients and the pharmacokinetics of
digitoxin in serum.
Funding Source-FDA OOPD